Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT02664701

Cognitive Behavioural Group Therapy Versus Individual Supportive Therapy for the Prevention of Repeat Suicide Attempts

Cognitive Behavioural Group Therapy Versus Individual Supportive Therapy for the Prevention of Repeat Suicide Attempts: a Multicentre, Assessor-blinded, 2-parallel-group, Randomised, Superiority Trial

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
240 (estimated)
Sponsor
Centre Hospitalier Universitaire de Nīmes · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary objective of this study is to evaluate the efficacy of a program of 6 sessions of Cognitive Behavioural Group Therapy (CBGT) (as compared to 6 sessions of Individual Supportive Therapy (IST)) designed for preventing repeat suicide attempts at 12 months post-psychotherapy in adults admitted to inpatient care for suicide attempts.

Detailed description

The secondary objectives of this study are to assess the efficacy of CBGT on: A. parameters describing the incidence of suicide and repeat suicide attempts, as well as suicide re-attempt free follow-up time, B. long-term changes in suicidal ideation, C. long-term changes in psychiatric symptoms (depression, hope for the future, hospitalization).

Conditions

Interventions

TypeNameDescription
OTHERBaseline evaluation with a psychiatristBaseline data and questionnaires are established.
OTHERIndividual supportive therapy6 sessions of individual supportive therapy with a psychologist, 1 session per week for 6 weeks
OTHERCognitive behavioural group therapy6 sessions of cognitive behavioural group therapy with a psychologist, 1 session per week for 6 weeks
OTHEREvaluations with a psychiatristEvaluation withs a psychiatrist in the 10 days following the end of psychotherapy, then at 3, 6, 9, and 12 months.

Timeline

Start date
2017-10-17
Primary completion
2025-11-01
Completion
2025-11-01
First posted
2016-01-27
Last updated
2025-08-20

Locations

9 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02664701. Inclusion in this directory is not an endorsement.